Risk group-adapted adjuvant radiotherapy for WHO grade I and II skull base meningioma

被引:0
|
作者
Sangjoon Park
Yoon Jin Cha
Sang Hyun Suh
Ik Jae Lee
Kyu-Sung Lee
Chang-Ki Hong
Jun Won Kim
机构
[1] Yonsei University College of Medicine,Department of Radiation Oncology, Gangnam Severance Hospital
[2] Yonsei University College of Medicine,Department of Pathology
[3] Yonsei University College of Medicine,Department of Radiology
[4] Yonsei University College of Medicine,Department of Neurosurgery, Gangnam Severance Hospital
关键词
Meningioma; WHO grade I/II; Skull base neoplasm; Adjuvant radiotherapy; Surgical extent; Risk factors;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1351 / 1360
页数:9
相关论文
共 50 条
  • [41] In Reply: Adjuvant Radiotherapy Versus Watchful Waiting for World Health Organization Grade II Atypical Meningioma: A Single-Institution Experience
    Bray, David P.
    Quillin, Joseph W.
    Press, Robert H.
    Yang, Yilin
    Chen, Zhengjia
    Eaton, Bree R.
    Olson, Jeffrey J.
    NEUROSURGERY, 2021, 89 (05) : E279 - E280
  • [42] Should adjuvant radiotherapy be used in atypical meningioma (WHO grade 2) following gross total resection? A systematic review and Meta-analysis
    Wujanto, Caryn
    Chan, Tabitha Y.
    Soon, Yu Yang
    Vellayappan, Balamurugan
    ACTA ONCOLOGICA, 2022, 61 (09) : 1075 - 1083
  • [43] Residual Tumor Volume and Tumor Progression after Subtotal Resection and Observation of WHO Grade I Skull Base Meningiomas
    Przybylowski, Colin J.
    Hendricks, Benjamin K.
    Furey, Charuta G.
    DiDomenico, Joseph D.
    Porter, Randall W.
    Sanai, Nader
    Almefty, Kaith K.
    Little, Andrew S.
    JOURNAL OF NEUROLOGICAL SURGERY PART B-SKULL BASE, 2022, 83 : E530 - E536
  • [44] Commentary: Adjuvant Radiotherapy Versus Watchful Waiting for World Health Organization Grade II Atypical Meningioma: A Single-Institution Experience
    Chicoine, Michael R.
    Kim, Albert H.
    NEUROSURGERY, 2021, 88 (05) : E443 - E444
  • [45] Differential effect of surgery and radiotherapy on neurocognitive functioning and health-related quality of life in WHO grade I meningioma patients
    David van Nieuwenhuizen
    Martin Klein
    Lukas J. A. Stalpers
    Sieger Leenstra
    Jan J. Heimans
    Jaap C. Reijneveld
    Journal of Neuro-Oncology, 2007, 84 : 271 - 278
  • [46] Differential effect of surgery and radiotherapy on neurocognitive functioning and health-related quality of life in WHO grade I meningioma patients
    van Nieuwenhuizen, David
    Klein, Martin
    Stalpers, Lukas J. A.
    Leenstra, Sieger
    Heimans, Jan J.
    Reijneveld, Jaap C.
    JOURNAL OF NEURO-ONCOLOGY, 2007, 84 (03) : 271 - 278
  • [47] Surgery alone versus surgery plus adjuvant radiotherapy for WHO grade 2 meningioma: meta-analysis of reconstructed time-to-event data
    Verly, Gabriel
    Bresciani, Lucas
    Delfino, Thiffany
    Nascimento, Marcos
    Magill, Stephen T.
    Galvao, Gustavo da Fontoura
    NEUROSURGICAL REVIEW, 2024, 47 (01)
  • [48] Letter: Commentary: Adjuvant Radiotherapy Versus Watchful Waiting for World Health Organization Grade II Atypical Meningioma: A Single-Institution Experience
    Bray, David P.
    Quillin, Joseph W.
    Press, Robert H.
    Yang, Yilin
    Chen, Zhengjia
    Eaton, Bree R.
    Olson, Jeffrey J.
    NEUROSURGERY, 2021, 89 (03) : E174 - E175
  • [49] In Reply: Commentary: Adjuvant Radiotherapy Versus Watchful Waiting for World Health Organization Grade II Atypical Meningioma: A Single-Institution Experience
    Chicoine, Michael R.
    Kim, Albert H.
    NEUROSURGERY, 2021, 89 (03) : E176 - E177
  • [50] Phase II MARCIE Study: postoperative bimodal Radiotherapy with Heavy Ion Boost in WHO Grade 2-3 Meningioma Patients
    Deng, M.
    Eichkorn, T.
    Kramer, A.
    Meixner, E.
    Sandrini, E.
    Hoerner-Rieber, J.
    Harrabi, S.
    Seidensaal, K.
    Unterberg, A.
    Wick, W.
    von Deimling, A.
    Sahm, F.
    Combs, S.
    Herfarth, K.
    Debus, J. Peter
    Koenig, L.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2022, 198 (SUPPL 1) : S26 - S27